Crohn’s & Colitis Foundation announces Sharon Lungrin as new member of senior leadership team

Lungrin begins her role as Chief Operating Officer on July 18

Sharon LungrinNEW YORK, NY – The Crohn’s & Colitis Foundation announced today the hire of Sharon Lungrin, an experienced strategy and operations professional, as its new Chief Operating Officer, beginning July 18. Lungrin comes to the Foundation with over 20+ years’ experience in the for-profit and non-profit sectors. In her new role, Sharon will be responsible for leading the Foundation’s Human Resources, Finance, Operations, and Legal departments.


“We’re thrilled to welcome Sharon to the Crohn’s & Colitis Foundation,” said Michael Osso, President & CEO of the Foundation. “Sharon’s experience building trust and delivering lasting solutions to complex systemic challenges will greatly benefit the Foundation as we continue our work to find cures for Crohn’s disease and ulcerative colitis and improve the lives of the millions of Americans affected by these diseases.”


“I am delighted to be joining the Foundation and look forward to working with the staff and volunteers to sustain and deepen the organization’s impact across the country,” Lungrin said.


Prior to joining the Crohn’s & Colitis Foundation, Sharon held positions at the Synergos Institute, Internationals Network for Public Schools, and the Whirlpool Corporation, as well as worked with the International Women’s Health Coalition and the Women’s Environment and Development Organization on the 1994 United Nations Conference on Population and Development Conference in Cairo. Sharon was raised in Jamaica and East New York, Brooklyn, and she and her family currently reside in the Bronx.

Crohn's & Colitis Foundation

The Crohn’s & Colitis Foundation is the leading nonprofit organization focused on both research and patient support for inflammatory bowel disease (IBD), with the mission of curing Crohn’s disease and ulcerative colitis and improving the quality of life for the millions of Americans living with IBD. The Foundation’s work is dramatically accelerating the research process, while also providing extensive educational and support resources for patients and their families, medical professionals, and the public.